Novo Nordisk said on Friday the U.S. Food and Drug Administration has granted accelerated approval for its weight-loss drug ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® ...

At 2 years, participants in the compensated MASH cirrhosis treatment arm of the MAESTRO-NAFLD-1 trial experienced a statistically significant 6.7 kPa reduction in liver stiffness from baseline.

GLP-1 RAs can reduce liver fat, fibrosis progression, and resolve MASH, offering potential benefits for liver health. MASH significantly increases healthcare costs due to comorbidities like ...

The rotation has frontline talent with Max Fried and Carlos Rodon, they just need to get back to that form. The bullpen has ...

SS Masyn Winn looked like the franchise player the #STLCards desperately need him to become on this play. He went behind 3B ...